Novartis (NVS) Fundamental Analysis: Revenue, Earnings & Valuation

7.87 / 10

Outperform

Fundamental analysis rates Novartis Outperform with a 7.9/10 score. Strong points include Days Sales Outstanding, Accounts Receivable Turnover, and robust Profit‑MV, Asset‑MV, PB‑ROE metrics. Caution arises from a higher Income‑Tax‑to‑Profit ratio. Overall, fundamentals appear very promising.

Analysis Checks(9/10)

Total operating revenue (YoY growth rate %)

Value9.57

Score2/3

Weight0.16%

1M Return0.07%

Days sales outstanding

Value54.00

Score2/3

Weight0.28%

1M Return0.11%

Accounts receivable turnover ratio

Value6.67

Score2/3

Weight-2.67%

1M Return-1.17%

Profit-MV

Value1.20

Score3/3

Weight30.73%

1M Return9.28%

PB-ROE

Value1.37

Score3/3

Weight38.60%

1M Return12.21%

Income tax / Total profit (%)

Value14.59

Score0/3

Weight-4.77%

1M Return-2.17%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.29

Score2/3

Weight-2.89%

1M Return-1.25%

Operating revenue (YoY growth rate %)

Value8.38

Score2/3

Weight0.15%

1M Return0.06%

Cost of sales ratio (%)

Value25.12

Score3/3

Weight3.13%

1M Return1.16%

Asset-MV

Value-0.55

Score3/3

Weight37.29%

1M Return10.81%

Is NVS fundamentally strong?

NVS scores 7.87/10 on fundamentals and holds a Discounted valuation at present. Backed by its 30.84% ROE, 24.64% net margin, 20.28 P/E ratio, 6.09 P/B ratio, and 21.79% earnings growth, these metrics solidify its Outperform investment rating.